Annex3 WHOguidelinesonvariationstoaprequali,edproduct Introduction96 1.Background97 1.1Objectives97 1.2Scopeandapplication98 2.Guidanceforimplementation99 2.1Reportingtypes99 2.1.1Noti,cations100 2.1.2Minorvariation(Vmin)101 2.1.3Majorvariation(Vmaj)101 ...
12、WHO_TRS_981附录2:WHO质量风险管理指南-英-2013.pdf 关闭预览 想预览更多内容,点击免费在线预览全文 免费在线预览全文 Annex2 WHOguidelinesonqualityriskmanagement 1.Introduction62 1.1Backgroundandscope62 1.2Principlesofqualityriskmanagement64 2.Glossary67 3.Qualityriskmanagementprocess70 3.1InitiatingaQRM...
WHO_TRS_961 Annex3 WHO GMP主要原理介绍.pdf,WHO GMP for pharmaceutical products: main principles WHO 技术指南报告No. 961, 2011, annex 3 WHO 药品GMP 主要原理 © World Health Organization WHO Technical Report Series, No. 961, 2011 世界卫生组织技术报告系列
[7] WHO. Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases[EB/OL]. (2021-07-22)[2021-10-05]. https://www. who.int/publications/m/item/annex-3-mRNA-vaccines-...
Annex3附录3 WHOgoodmanufacturingpracticesforpharmaceuticalproducts:mainprinciples世界卫 生组织药品GMP主要原理 Introduction介绍 Generalconsiderations总则 Glossary术语表 Qualitymanagementinthemedicinesindustry:philosophyandessentialelements药业的质量 管理:理念和基本要素 ...
1 © World Health Organization WHO Technical Report Series, No. 961 , 201 1 世界卫生组织技术报告系列, 编号961, 2011 年 Annex 3 附录3 WHO good manufacturing practices for pharmaceutical products: main principles 世界卫生组织药品GMP主要原理 Introduction 介绍 General considerations 总则 Glossary 术语表...
© World anization WHO Technical Report Series, No. 961, 2011 世界卫生组织技术报告系列,编号961,2011年 Annex 3 附录3 WHO good manufacturing practices for pharmaceutical products: main principles 世界卫生组织药品GMP主要原理 Introduction 介绍
[7] WHO. Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases[EB/OL]. (2021-07-22)[2021-10-05]. https://www. who.int/publications/m/item/annex-3-mRNA-vaccines-trsno-1039. ...
Geneva: World Health Organization; 2013: Annex 2 (WHO Technical Report Series, No. 981; https://www.who.int/medicines/areas/quality_safety/quality_assurance/Annex2TRS-981.pdf, accessed 8 February 2019). 本站仅提供存储服务,所有内容均由用户发布,如发现有害或侵权内容,请点击举报。
WHO TRS 1022 第55 次 报告 Annex 3 Good manufacturing practices: water for pharmaceutical use 优良生产规范( GMP ): 制药用水 Background 背景 Unlike other product or process ingredients, water is usually drawn from an on demand system and is not subject to testing and batch or lot release ...